Persistent fatigue. Belly fat that won’t move no matter how well you eat. A libido that’s gone quiet. Brain fog that makes concentrating feel like an effort. If you’ve been researching these symptoms online, you’ve probably landed on two possible explanations: low testosterone and growth hormone deficiency. The problem is that both conditions share a remarkably similar symptom profile — and the two are often confused, misdiagnosed, or treated as the same thing.
They’re not. While testosterone and growth hormone (GH) work closely together in the body and sometimes decline in tandem, they are separate hormones controlled by different systems. Understanding what each one does — and how each deficiency presents — is the first step toward getting an accurate diagnosis and an effective treatment plan.
What These Two Hormones Actually Do
Before comparing deficiency symptoms, it helps to understand the role each hormone plays in adult physiology.
Testosterone is the primary male sex hormone, produced mainly in the testes under the direction of luteinizing hormone (LH) from the pituitary gland. It governs libido, sperm production, bone density, red blood cell production, mood regulation, and muscle maintenance. Testosterone levels begin declining gradually after age 30, typically at a rate of about 1–2% per year.
Human growth hormone (HGH) is produced by the pituitary gland and released in pulses throughout the day, with the largest surge occurring during deep sleep. In adulthood, HGH is not about height — it regulates cellular repair, fat metabolism, body composition, and the renewal of organs and connective tissue. GH works largely through a downstream hormone called IGF-1 (insulin-like growth factor 1), which mediates many of its effects. Adult GH secretion also declines with age, falling by roughly 14% per decade after peak levels in young adulthood.
Key distinction: Testosterone deficiency is primarily a reproductive and androgen issue. Growth hormone deficiency (GHD) is primarily a metabolic and regenerative issue. The two can and do co-exist — but they require different tests and different treatments.
Symptoms: Where They Overlap
The significant overlap between the two conditions is what makes self-diagnosis so difficult. Both deficiencies can cause:
Despite the overlap, there are meaningful differences in how each deficiency tends to present. Paying attention to these can help you have a more productive conversation with your doctor and point toward the right testing.
GH is secreted during slow-wave sleep; poor sleep drives deficiency
Can You Have Both at the Same Time?
Yes, and it’s more common than most people realize. The hypothalamic-pituitary axis controls the release of both LH (which stimulates testosterone production) and growth hormone. Conditions that impair pituitary function — including pituitary tumors, head trauma, radiation therapy, and age-related decline — can reduce both hormones simultaneously.
Additionally, there is a functional relationship between testosterone and GH. Testosterone stimulates GH release in some circumstances, meaning that chronically low testosterone can blunt normal growth hormone secretion. Men on TRT who still feel fatigued, mentally foggy, or have persistently elevated abdominal fat should consider testing GH/IGF-1 levels — these symptoms may point to a co-existing growth hormone deficiency.
Clinical note:
Adult growth hormone deficiency is likely underdiagnosed in men already receiving TRT. Because the symptoms overlap significantly with low testosterone, GHD is often assumed to be “residual” low T — especially when a patient reports incomplete improvement after starting testosterone therapy. If you’re on TRT and still experiencing persistent fatigue, poor body composition results, or cognitive symptoms despite normal testosterone levels, ask your provider about IGF-1 testing.
How Each Is Diagnosed
Diagnosis requires blood testing — symptoms alone are not sufficient for either condition, and the tests are different.
Testing for low testosterone
A morning serum total testosterone is the standard first test. If total testosterone is low or borderline, free testosterone and SHBG (sex hormone-binding globulin) should be measured, as SHBG levels affect how much testosterone is biologically available. LH and FSH levels help determine whether the problem originates in the testes (primary hypogonadism) or the pituitary (secondary hypogonadism).
Testing for growth hormone deficiency
A single random GH level is not useful because GH is released in unpredictable pulses. Instead, IGF-1 is the standard screening test — it reflects average GH secretion over time and is stable throughout the day. If IGF-1 is low, stimulation testing (such as the glucagon stimulation test or macimorelin test) may be used to confirm GHD. Comprehensive hormone panels including thyroid function, cortisol, and prolactin are also typically ordered, as other pituitary hormones can be affected alongside GH.
What to ask for when you see your provider:
Total testosterone (morning draw)
Free testosterone and SHBG
LH and FSH
IGF-1 (growth hormone screening)
Comprehensive metabolic panel
Lipid panel (elevated LDL can support GHD)
Thyroid function (TSH, free T4)
Prolactin (elevated levels impair both GH and testosterone)
Treatment: Different Paths
Treatment for each condition is distinct and should only be initiated after confirmed diagnosis.
Adult growth hormone deficiency is treated with recombinant human growth hormone (HGH) administered by subcutaneous injection, typically once daily. Dosing is individualized and adjusted based on IGF-1 response and symptom improvement. Peptide therapies that stimulate natural GH release — such as the CJC-1295 and Ipamorelin combination — are also increasingly used in appropriate candidates.
When both conditions are present, they are typically treated together, as addressing only one may produce incomplete results. The sequence and dosing are determined by a specialist based on the full clinical picture.
Frequently Asked Questions
Can low testosterone cause growth hormone deficiency?
Not directly, but the two are functionally connected. Testosterone has a stimulatory effect on growth hormone secretion. Chronically low testosterone can blunt GH pulsatility over time, meaning that long-standing testosterone deficiency may contribute to suboptimal GH levels. More commonly, both conditions share a root cause — impaired pituitary function — rather than one causing the other.
Is IGF-1 testing part of a standard hormone panel?
Not always. A basic hormone panel ordered by a general practitioner typically includes testosterone, LH, FSH, and thyroid function. IGF-1 testing is not universally included unless you or your doctor specifically request it. If you are experiencing symptoms that don’t fully resolve on TRT, or if you have a history of pituitary issues, ask your provider to add IGF-1 to your workup.
What’s the difference between low IGF-1 and clinical GHD?
Low IGF-1 is a screening result that suggests reduced average GH secretion. A formal diagnosis of adult growth hormone deficiency typically requires confirmatory stimulation testing in addition to a low IGF-1, along with consistent clinical symptoms and often evidence of pituitary pathology. An endocrinologist will determine whether stimulation testing is necessary based on your clinical picture.
If I’m already on TRT, should I also test for GHD?
If you’ve been on TRT for several months with optimized levels and still experience significant fatigue, poor body composition despite adequate training and nutrition, cognitive symptoms, or notably poor recovery, it’s worth discussing IGF-1 testing with your provider. These persistent symptoms on adequately-dosed TRT may indicate a co-existing growth hormone deficiency that TRT alone won’t address.
Are the symptoms of GHD the same in men and women?
The core metabolic symptoms — increased abdominal fat, reduced lean mass, fatigue, poor recovery, cognitive changes, and elevated lipids — are similar across sexes. Women with GHD may also notice more pronounced skin changes and a greater impact on quality of life measures. Testing and treatment are broadly the same, though dosing protocols for HGH replacement often differ slightly based on sex and estrogen status.
How long does it take to feel results from HGH therapy?
Most patients begin noticing improved sleep quality and subtle energy improvements within the first 4–6 weeks. More meaningful changes in body composition — reduction in visceral fat, improvement in lean mass — typically become apparent at 3–6 months. Skin quality improvements are often reported at 3–4 months. Full metabolic benefits, including improvements in cholesterol and bone density, may take 12 months or longer of consistent therapy.
Can I treat GHD without daily injections?
Peptide therapies — particularly GHRH analogues like CJC-1295 combined with GHRP agents like Ipamorelin — work by stimulating the pituitary’s own GH release rather than replacing it exogenously. They are typically injected subcutaneously 2–3 times per week or at bedtime, and some patients prefer them as a less intensive alternative. However, they are generally better suited for patients with partial deficiency or age-related GH decline rather than severe, confirmed GHD where the pituitary’s response capacity may be limited.
This article is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. All hormone therapies are prescription treatments and must be initiated and managed by a licensed healthcare professional. If you are experiencing symptoms described in this article, consult a qualified provider for evaluation.
